BATOOL SALEEM: Open Payments
NPI 1134531379 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$332 in 14 payments from 10 companies in 2025. Trend: 2023 $87 · 2024 $186 · 2025 $332
Food & beverage: $332
| Company | Payments | Amount |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 2 | $55 |
| PFIZER INC. | 2 | $50 |
| ARRAY BIOPHARMA INC | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
| SERVIER PHARMACEUTICALS LLC | 1 | $23 |
| Astellas Pharma US Inc | 1 | $22 |
| Karyopharm Therapeutics Inc. | 1 | $21 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
Products named: QINLOCK, Xtandi, XALKORI, KEYTRUDA, OPDIVO, PADCEV, ICLUSIG, Voranigo.
Industry payments across TX — which companies pay providers there.
